A Study of ZEN003694 in Combination With Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT02711956 · COMPLETED
Trial details
- NCT number
- NCT02711956
- Sponsor
- Zenith Epigenetics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-11-01
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.